Results 151 to 160 of about 30,900 (164)

Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib. [PDF]

Sci Rep
Klaihmon P, Lorthongpanich C, Kheolamai P, Saisaard W, Issaragrisil S.   +4 more
europepmc   +1 more source

Identification of Philadelphia-negative granulocyte-macrophage colony- forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients [PDF]

, 1994
Carmelo Carlo‐Stella, L Mangoni, Giovanna Piovani, D. Garau, Camillo Almici, Vittorio Rizzoli   +5 more
openalex   +1 more source

AN AUTOPSY CASE OF SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH CHRONIC MYELOGENOUS LEUKEMIA

, 1981
Makiko ANNO, Yasumitu NAKAIDE, Masao Tanaka, Yutaka Hirota, Kazuo Hara   +4 more
openalex   +2 more sources

Bone marrow transplantation for chronic myelogenous leukemia [letter; comment] [PDF]

, 1994
MR Litzow, A Tefferi
openalex   +1 more source

Association of Nilotinib With Cardiovascular Diseases in Patients With Chronic Myelogenous Leukemia: A National Population-Based Cohort Study. [PDF]

Oncologist
Huang CE, Lee KD, Chang JJ, Tzeng HE, Huang SH, Yu LH, Chen MC.   +6 more
europepmc   +1 more source

STUDIES ON THE LONG-TERM SURVIVORS IN CHRONIC MYELOGENOUS LEUKEMIA AND THE CHEMOTHERAPY OF ITS BLASTIC PHASE

, 1983
Nakayuki Kitagawa
openalex   +2 more sources

Prominent leukemic infiltration in the lower gastrointestinal tract in a patient with chronic myelogenous leukemia(CML).

, 1989
Shinsuke Iida, Masakazu Nitta, Osamu Nojiri, Genji Takeuchi, Hiroyuki Kodama, K Kohsaka, N Kamejima, Katsutoshi Takada, Y Mitomo, Masahiko Yamamoto   +9 more
openalex   +2 more sources